# Specific Interventions for Agitation in Alzheimer's Disease

> **NCT00018291** · NA · COMPLETED · sponsor: **US Department of Veterans Affairs**

## Conditions studied

- Alzheimer's Disease
- Dementia

## Interventions

- **DRUG:** Risperidone
- **DRUG:** Gabapentin

## Key facts

- **NCT ID:** NCT00018291
- **Lead sponsor:** US Department of Veterans Affairs
- **Sponsor class:** FED
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** —
- **Final completion:** 2005-01
- **Target enrollment:** — (—)
- **Last updated:** 2009-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00018291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00018291, "Specific Interventions for Agitation in Alzheimer's Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00018291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*